We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,990 hedge funds and large institutions have $267B invested in Johnson & Johnson in 2019 Q4 according to their latest regulatory filings, with 373 funds opening new positions, 1,140 increasing their positions, 1,233 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

465% more first-time investments, than exits

New positions opened: 373 | Existing positions closed: 66

22% more funds holding in top 10

Funds holding in top 10: 485592 (+107)

14% more capital invested

Capital invested by funds: $233B → $267B (+$33.7B)

14% more call options, than puts

Call options by funds: $2.66B | Put options by funds: $2.33B

10% more funds holding

Funds holding: 2,7242,990 (+266)

1.21% more ownership

Funds ownership: 68.38%69.59% (+1.2%)

8% less repeat investments, than reductions

Existing positions increased: 1,140 | Existing positions reduced: 1,233

Holders
2,990
Holders Change
+266
Holders Change %
+9.77%
% of All Funds
58.92%
Holding in Top 10
592
Holding in Top 10 Change
+107
Holding in Top 10 Change %
+22.06%
% of All Funds
11.67%
New
373
Increased
1,140
Reduced
1,233
Closed
66
Calls
$2.66B
Puts
$2.33B
Net Calls
+$334M
Net Calls Change
+$537M
Name Holding Trade Value Shares
Change
Change in
Stake
ARMC
801
American Research & Management Company
Massachusetts
$11M -$187K -1,375 -2%
CAM
802
Claret Asset Management
Quebec, Canada
$10.9M -$30.1K -222 -0.3%
PPSG
803
Princeton Portfolio Strategies Group
New Jersey
$10.9M -$69.2K -510 -0.7%
WCMN
804
Westchester Capital Management (Nebraska)
Nebraska
$10.9M +$668K +4,925 +7%
GIM
805
Grassi Investment Management
California
$10.9M +$724K +5,339 +8%
SAM
806
Strategy Asset Managers
California
$10.8M -$415K -3,060 -4%
ECM
807
Everence Capital Management
Indiana
$10.8M +$997K +7,348 +11%
WP
808
WMS Partners
Maryland
$10.8M -$882K -6,499 -8%
Rafferty Asset Management
809
Rafferty Asset Management
New York
$10.8M +$8.86M +65,286 +752%
CB
810
Community Bank
New York
$10.8M -$149K -1,102 -1%
JIR
811
James Investment Research
Ohio
$10.8M +$42.3K +312 +0.4%
PCMI
812
Paradigm Capital Management Inc
New York
$10.8M
BWFA
813
Baltimore-Washington Financial Advisors
Maryland
$10.7M -$638K -4,702 -6%
UR
814
USCA RIA
Texas
$10.7M -$153K -1,130 -2%
EFS
815
Essex Financial Services
Connecticut
$10.6M +$189K +1,394 +2%
CANC
816
Culbertson A N & Co
Virginia
$10.6M -$61.4K -453 -0.6%
RP
817
Rowlandmiller & Partners
Georgia
$10.6M +$131K +966 +1%
SLI
818
Sumitomo Life Insurance
Japan
$10.6M +$553K +4,077 +6%
AAS
819
Avantax Advisory Services
Texas
$10.5M +$2.5M +18,426 +34%
NA
820
NewEdge Advisors
Louisiana
$10.5M -$97.1K -716 -1%
MLL
821
Moody Lynn & Lieberson
Massachusetts
$10.5M -$1.2M -8,873 -11%
RSVP
822
Ramsay Stattman Vela & Price
Colorado
$10.5M +$164K +1,208 +2%
BCM
823
BTC Capital Management
Iowa
$10.4M +$185K +1,363 +2%
JPMIA
824
J.P. Marvel Investment Advisors
Massachusetts
$10.4M -$81.4K -600 -0.8%
SFS
825
Sowell Financial Services
Arkansas
$10.4M +$98.2K +724 +1%

JNJ Hedge Fund Activity: Q4 2019 in Review

2,990 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2019, worth a combined $267B — up 14% from $233B a quarter earlier.

Buyers outnumbered sellers: 373 funds opened new JNJ positions and 66 closed out — a net gain of 307 holders — while 1,140 added to existing stakes and 1,233 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $783M. The largest seller was Capital World Investors, cutting an estimated $1.27B.

  • 2,990 institutional investors held Johnson & Johnson (JNJ) as of Q4 2019, up from 2,724 in Q3 2019.
  • Funds reported $267B of Johnson & Johnson stock for Q4 2019, up 14% quarter-over-quarter.
  • 373 funds opened new Johnson & Johnson positions in Q4 2019 and 66 closed out, a net change of +307 holders.
  • The largest Johnson & Johnson buyer in Q4 2019 was JP Morgan Chase, an estimated $783M added.
  • The largest Johnson & Johnson seller in Q4 2019 was Capital World Investors, an estimated $1.27B sold.

Based on aggregated 13F filings for Q4 2019.